Cumulative effects of raloxifene on the incidence of breast cancer over 8 years in postmenopausal women with osteoporosis.

被引：0
|
作者：
Mershon, J.
Yea, A.
Qu, Y.
Wong, M.
Mitchell, B.
Vogel, V.
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S180 / S180
页数：1
相关论文
共 50 条
  • [1] Breast cancer risk reduction over 8 years in postmenopausal women with osteopenia or osteoporosis receiving raloxifene
    Delmas, PD
    Cauley, JA
    Burshell, AL
    Secrest, RJ
    Song, J
    Cantor, P
    [J]. BONE, 2005, 36 : S436 - S437
  • [2] Cumulative Yearly Effects of Raloxifene on the Risk of Vertebral Fractures and Invasive Breast Cancer in Postmenopausal Women with Osteoporosis
    Wong, Mayme
    Liu, Chunhua
    Qu, Yongming
    Helt, Cameron
    Stock, John L.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1226 - 1226
  • [3] Effect of raloxifene hydrochloride on postmenopausal Japanese women with osteoporosis.
    Morii, H
    Orimo, H
    Taketani, Y
    Ishii, J
    Inoue, T
    Fujita, T
    Ohashi, Y
    Huster, WJ
    Lakshmanan, M
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T588 - T588
  • [4] Effect of raloxifene on the incidence of invasive breast cancer in postmenopausal women with osteoporosis categorized by breast cancer risk
    Lippman, Marc E.
    Cummings, Steven R.
    Disch, Damon P.
    Mershon, John L.
    Dowsett, Sherie A.
    Cauley, Jane A.
    Martin, Silvana
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (17) : 5242 - 5247
  • [5] Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis.
    Adachi, JD
    Reginster, J
    Qu, Y
    Siddhanti, S
    Keech, C
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S379 - S379
  • [6] Validation of the Gail model for breast cancer risk in postmenopausal women with osteoporosis.
    Goldstein, S.
    Yeo, A.
    Qu, Y.
    Wong, M.
    Mitchell, B.
    Mershon, J.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S175 - S176
  • [7] Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years
    Jolly, EE
    Bjarnason, NH
    Neven, P
    Plouffe, L
    Johnston, CC
    Watts, SD
    Arnaud, CD
    Mason, TM
    Crans, G
    Akers, R
    Draper, MW
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (04): : 337 - 344
  • [8] Incidence of invasive breast cancer following 8 years of raloxifene therapy in postmenopausal women with osteoporosis: Results from the Continuing Outcomes Relevant to Evista (CORE) trial.
    Martino, S
    Cauley, JA
    Barrett-Connor, E
    Powles, TJ
    Mershon, JL
    Disch, D
    Secrest, RJ
    Cummings, SR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 97S - 97S
  • [9] Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women
    Lee, Wen-Ling
    Chao, Hsiang-Tai
    Cheng, Ming-Huei
    Wang, Peng-Hui
    [J]. MATURITAS, 2008, 60 (02) : 92 - 107
  • [10] Comparison of the effect of raloxifene on bone between Japanese and Caucasian postmenopausal women with osteoporosis.
    Nakamura, T
    Matsumoto, T
    Fukunaga, M
    Watts, S
    Harper, KD
    Uesaka, H
    Tsujimoto, M
    Hamaya, E
    Sato, K
    Tanaka, A
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S301 - S301
12345